Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FIEE
FI Enhanced Europe 50 ETN
FIEE
|
+$334M |
| 2 |
Goldman Sachs
GS
|
+$280M |
| 3 |
Capital One
COF
|
+$81.6M |
| 4 |
NXP Semiconductors
NXPI
|
+$78.2M |
| 5 |
Lloyds Banking Group
LYG
|
+$70.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FEEU
Barclays ETN+ FI Enhanced Europe 50 ETN
FEEU
|
+$267M |
| 2 |
Citigroup
C
|
+$175M |
| 3 |
Bank of America
BAC
|
+$112M |
| 4 |
CS
Credit Suisse Group
CS
|
+$109M |
| 5 |
American Express
AXP
|
+$77.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.39% |
| 2 | Technology | 14.47% |
| 3 | Healthcare | 13.22% |
| 4 | Consumer Discretionary | 8.36% |
| 5 | Industrials | 6.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Hanmi Financial
HAFC
$945M
| $2.3M | ﹤0.01% |
87,298
-25,528
| -23% | -$643K |
|
|
SCLN
402
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $2.28M | ﹤0.01% |
222,827
-75,187
| -25% | -$819K |
|
403
Nike
NKE
$61.9B
| $2.23M | ﹤0.01% |
42,300
+364
| +0.9% | +$20.5K |
|
404
AT&T
T
$159B
| $2.23M | ﹤0.01% |
72,599
+6,607
| +10% | +$209K |
|
|
MCHB
405
Mechanics Bancorp
MCHB
$3.72B
| $2.2M | ﹤0.01% |
87,940
-26,948
| -23% | -$635K |
|
406
Quanex
NX
$819M
| $2.18M | ﹤0.01% |
126,193
-31,228
| -20% | -$603K |
|
|
CONE
407
DELISTED
CyrusOne Inc Common Stock
CONE
| $2.17M | ﹤0.01% |
45,533
-16,167
| -26% | -$836K |
|
408
Werner Enterprises
WERN
$2.24B
| $2.12M | ﹤0.01% |
91,276
-27,413
| -23% | -$651K |
|
409
General Dynamics
GD
$104B
| $2.12M | ﹤0.01% |
13,640
+159
| +1% | +$23.7K |
|
|
WLH
410
DELISTED
WILLIAM LYON HOMES
WLH
| $2.09M | ﹤0.01% |
112,493
-34,184
| -23% | -$581K |
|
|
JOYY
411
JOYY Inc
JOYY
$3.71B
| $2.06M | ﹤0.01% |
+38,582
| New | +$1.76M |
|
|
NSANY
412
DELISTED
NISSAN MOTOR CO LTD SPONS ADR
NSANY
| $2.05M | ﹤0.01% |
105,814
-4,458
| -4% | -$86.5K |
|
413
Rexford Industrial Realty
REXR
$8.42B
| $2.03M | ﹤0.01% |
88,623
-29,057
| -25% | -$643K |
|
414
Banner Corp
BANR
$2.39B
| $2.02M | ﹤0.01% |
46,064
-14,811
| -24% | -$638K |
|
415
CF Industries
CF
$19.2B
| $2M | ﹤0.01% |
82,282
-12,495
| -13% | -$305K |
|
|
SIGM
416
DELISTED
Sigma Designs Inc
SIGM
| $1.94M | ﹤0.01% |
249,267
-72,904
| -23% | -$528K |
|
417
Williams-Sonoma
WSM
$26.9B
| $1.93M | ﹤0.01% |
75,452
+310
| +0.4% | +$8.11K |
|
418
Myriad Genetics
MYGN
$270M
| $1.9M | ﹤0.01% |
92,381
+145
| +0.2% | +$3.68K |
|
419
Lowe's Companies
LOW
$117B
| $1.89M | ﹤0.01% |
26,168
+2,248
| +9% | +$175K |
|
|
PTLA
420
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $1.88M | ﹤0.01% |
82,737
| – | – |
|
|
IL
421
DELISTED
IntraLinks Holdings Inc.
IL
| $1.87M | ﹤0.01% |
185,864
-57,347
| -24% | -$486K |
|
422
TechnipFMC
FTI
$28.1B
| $1.86M | ﹤0.01% |
84,176
-10,958
| -12% | -$222K |
|
423
Colgate-Palmolive
CL
$73.1B
| $1.83M | ﹤0.01% |
24,639
+918
| +4% | +$67.9K |
|
424
DHI Group
DHX
$182M
| $1.82M | ﹤0.01% |
230,489
-71,823
| -24% | -$524K |
|
425
iShares Global Healthcare ETF
IXJ
$4.07B
| $1.8M | ﹤0.01% |
35,844
+596
| +2% | +$30.6K |
|
Similar funds
Ken Fisher's Q3 2016 Portfolio in Review
As of Q3 2016, Ken Fisher held 812 positions worth $56.3B, up 4.5% from $53.9B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ken Fisher's Q3 2016 filing shows 67 new, 303 increased, 278 reduced and 36 closed positions. Its largest new stake was iShares Europe ETF: 130,527 shares worth $5.14M. The largest sale was Barclays ETN+ FI Enhanced Europe 50 ETN, an estimated $267M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
- Ken Fisher's largest Q3 2016 buy was iShares Europe ETF: 130,527 shares worth $5.14M.
- Ken Fisher added most to FI Enhanced Europe 50 ETN in Q3 2016, an estimated $334M increase.
- Ken Fisher's biggest Q3 2016 reduction was Barclays ETN+ FI Enhanced Europe 50 ETN, cutting an estimated $267M.
- Ken Fisher fully exited PrivateBancorp Inc in Q3 2016, selling an estimated $61.3M.
- Ken Fisher's ten largest holdings make up 23% of its $56.3B portfolio in Q3 2016.
- Ken Fisher opened 67 new positions and closed 36 in Q3 2016.
- Ken Fisher's portfolio value rose 4.5% quarter-over-quarter to $56.3B.
Based on Fisher Asset Management's 13F filing for Q3 2016, filed 11 Oct 2016.